Bioxytran Inc.

Bioxytran Inc. Bioxytran, Inc. is a BioPharma company whose mission is to develop anti-necrosis drugs that treat a

BIOXYTRAN, INC. (OTCQB: BIXT) is pleased to announce the initiation of coverage of its stock by Independent Research, a ...
11/13/2025

BIOXYTRAN, INC. (OTCQB: BIXT) is pleased to announce the initiation of coverage of its stock by Independent Research, a global equity research firm specializing in micro-cap and small-cap public companies.

Read the full press release:
https://tinyurl.com/9sjtm4d3

Bioxytran ($BIXT) is pleased to announce the successful completion of its second randomized double-blind, placebo-contro...
11/12/2025

Bioxytran ($BIXT) is pleased to announce the successful completion of its second randomized double-blind, placebo-controlled clinical trial for its leading broad-spectrum antiviral drug candidate, ProLectin-M. Data from the trial is expected to inform both the CDSCO for a phase 3 trial design and will also be submitted to the FDA pursuant to their request.

READ FULL PRESS RELEASE:
https://tinyurl.com/bdw7nac8

Bioxytran ($BIXT) Secures a Source of GMP Quality Camel Hemoglobin. 1) First use of camel hemoglobin as a universal oxyg...
06/20/2025

Bioxytran ($BIXT) Secures a Source of GMP Quality Camel Hemoglobin.
1) First use of camel hemoglobin as a universal oxygen carrier.
2) Unique properties make it an ideal ingredient for oxygen transport.

READ THE FULL PRESS RELEASE:
https://tinyurl.com/2s4xkzu8
đź”— IN PROFILE

$BIXT announced that Bioxtran’s Science Advisor Prof. Avraham Mayevsky’s book titled "The Mongolian Gerbil Brain: Mitoch...
06/03/2025

$BIXT announced that Bioxtran’s Science Advisor Prof. Avraham Mayevsky’s book titled "The Mongolian Gerbil Brain: Mitochondrial Function, Vasculature, and Pathophysiological States" was published by a publishing house, Springer.

This book serves as a scientific cornerstone for Bioxytran’s clinical development program of the universal oxygen carrier (UOC) in ischemic stroke and Alzheimer’s disease, and is directly tied to the use of the MDX Viewer as an analytical method to detect a brain regions response to the addition of a UOC.

Read the full press release here:
https://tinyurl.com/ycdbt2b4

$BIXTBioxytran announced UGA confirmed the antiviral PHM23 was to be included in its grant submission to the U.S. Depart...
05/21/2025

$BIXT
Bioxytran announced UGA confirmed the antiviral PHM23 was to be included in its grant submission to the U.S. Department of Agriculture’s (USDA) $100 million Highly Pathogenic Avian Influenza (HPAI) Poultry Innovation Grand Challenge.

READ FULL PRESS RELEASE ON OUR WEBSITE: đź”— IN PROFILE
https://tinyurl.com/mwmjcj6d

$BIXTBioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chick...
03/19/2025

$BIXT
Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens. The research will be led by Dr. Daniel Perez, a renowned expert in virology and poultry medicine, who holds multiple prestigious positions at the University of Georgia, including CVI Affiliated Faculty and Caswell Eidson Chair in Poultry Medicine.

READ THE FULL PRESS RELEASE HERE 👉🏻 https://tinyurl.com/43wv43w7

$BIXT develops a GROUNDBREAKING TREATMENT to combat BIRD FLU in egg-laying chickens potentially saving billions.READ FUL...
03/12/2025

$BIXT develops a GROUNDBREAKING TREATMENT to combat BIRD FLU in egg-laying chickens potentially saving billions.

READ FULL PRESS RELEASE!
👉🏻 https://tinyurl.com/5acjthnp

$BIXT CCO Mike Sheikh will be attending PMWC 2025 from February 5–7, 2025 to network with Big & Small Pharma for licensi...
01/29/2025

$BIXT CCO Mike Sheikh will be attending PMWC 2025 from February 5–7, 2025 to network with Big & Small Pharma for licensing & partnership opportunities.

Connect with on overcoming Immune Checkpoint Resistance in & the reality of Broad Spectrum Antivirals capable of defeating Quadremic outbreaks. mike.sheikh@bioxytraninc.com

Key speakers will be $NVDA Jensen Huang & Nobel Laureate Carolyn Bertozzi.

BIOXYTRAN $BIXT announced it has entered into a common stock purchase agreement (the “SPA”) with TRITON FUNDS LP for $1,...
01/22/2025

BIOXYTRAN $BIXT announced it has entered into a common stock purchase agreement (the “SPA”) with TRITON FUNDS LP for $1,600,000.

"TRITON FUNDS recognizes Bioxytran’s steadfast commitment to advancing its core thesis on the potential of Galectin Antagonists and eagerly anticipates the outcomes of upcoming trials.”, said Axel Olson, Equity Analyst and Entrepreneur in Residence at TRITON FUNDS.

READ FULL PRESS RELEASE:
https://tinyurl.com/4xcfdnur

$BIXT A well-attended Techwatch Light meeting, hosted by the Biomedical Advanced Research and Development Authority (BA...
01/09/2025

$BIXT A well-attended Techwatch Light meeting, hosted by the Biomedical Advanced Research and Development Authority (BARDA), introduced Bioxytran to the government to help facilitate and direct the Company’s approach toward finding programs within the government capable of funding its development initiatives.

READ FULL PRESS RELEASE
https://tinyurl.com/5654s282

Bioxytran CCO Mike Sheikh will talk about the Medical Breakthrough in & his LinkedIn article on in his interview on...
10/30/2024

Bioxytran CCO Mike Sheikh will talk about the Medical Breakthrough in & his LinkedIn article on in his interview on Thursday, October 31, 2024 from 1:10 - 1:40 PM Eastern.

Click to register: https://tinyurl.com/4rhsndbm

$BIXTBioxytran CCO Mike Sheikh will take on cancer metastasis in his interview at the Emerging Growth Conference on Thur...
09/25/2024

$BIXT
Bioxytran CCO Mike Sheikh will take on cancer metastasis in his interview at the Emerging Growth Conference on Thursday, Sept. 26, 2025 from 11:25 AM to 11:55 AM Eastern.

Please click the registration link:
https://tinyurl.com/3hpkm9j8

Address

233 Needham Street
Newton, MA
02459

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+16174541199

Website

https://linkedin.com/pulse/bird-flu-headlines-should-we-concerned-terrified-michael-sheikh

Alerts

Be the first to know and let us send you an email when Bioxytran Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Bioxytran Inc.:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram